¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"universal serologic reaction"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • immunoprecipitation reaction
    ¸é¿ªÄ§Àü¹ÝÀÀ
  • id reaction
    ¼ÓÁø¹ÝÀÀ, À̵å¹ÝÀÀ
  • indirect immunofluorescence reaction
    °£Á¢¸é¿ªÇü±¤¹ÝÀÀ
  • indophenol reaction
    ÀεµÆä³î°Ë»ç
  • induced reaction
    À¯¹ß¹ÝÀÀ
  • inhibition reaction
    ¾ïÁ¦¹ÝÀÀ
  • interface reaction
    °æ°è¸é¹ÝÀÀ
  • intermediate reaction
    Áß°£¹ÝÀÀ
  • intermicellar reaction
    ¹Ì¼¼¸£°£¹ÝÀÀ
  • Jarisch-Herxheimer reaction
    ¾ß¸®½´-Ç츣ũ½ºÇÏÀ̸ӹÝÀÀ
  • johnin reaction
    ¿ä´Ñ¹ÝÀÀ
  • labile oxidase reaction
    ºÒ¾ÈÁ¤»êÈ­È¿¼Ò¹ÝÀÀ
  • lengthening reaction
    1. ´ÃÀÓ¹ÝÀÀ, ½ÅÀå¹ÝÀÀ 2. ±Ù´ÃÀÓ¹ÝÀÀ
  • lepra reaction
    ³ªº´¹ÝÀÀ
  • lepromin reaction
    ·¹ÇÁ·Î¹Î¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • Herxheimer¡¯s reaction
    (¢¡Jarisch-Herxheimer reaction) ¾ß¸®½ÃÇ츤½ºÇÏÀ̸ӹÝÀÀ
  • heterogeneous reaction
    ºÒ±ÕÀϹÝÀÀ, ºÒ±ÕÁú¹ÝÀÀ
  • heterophil antibody reaction
    ÀÌÁ¾Ä£È­Ç×ü¹ÝÀÀ
  • homograft reaction
    µ¿Á¾À̽ĹÝÀÀ
  • hopping reaction
    µµ¾à¹ÝÀÀ, ¾Ó°¨Áú¹ÝÀÀ
  • humoral reaction
    ü¾×¹ÝÀÀ
  • hyperkinetic reaction
    °ú´Ù¿îµ¿¹ÝÀÀ
  • hypersensitivity reaction
    °ú¹Î¹ÝÀÀ
  • hypnic reaction
    ¼ö¸é¹ÝÀÀ
  • hysteric reaction
    È÷½ºÅ׸®¹ÝÀÀ
  • id reaction
    ¼ÓÁø¹ÝÀÀ
  • immune reaction
    ¸é¿ª¹ÝÀÀ
  • immune adherence reaction
    ¸é¿ªºÎÂø¹ÝÀÀ
  • immunologic reaction
    (¢¡immune) ¸é¿ª¹ÝÀÀ
  • immunological reaction
    (¢¡immune) ¸é¿ª¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • pyrogenic reaction
    ¹ß¿­¹ÝÀÀ.
  • pyrogenic reaction
    ¹ß¿­¹ÝÀÀ(Û¡æðÚãëë)
  • pyrrole reaction
    ÇǷѹÝÀÀ(¡­Úãëë).
  • quellung reaction
    ÆØÃ¢¹ÝÀÀ(ø³óìÚãëë).
  • rage reaction
    ³ë¹ÝÀÀ(ÖÍÚãëë).
  • rate limiting reaction
    ¼ÓµµÁ¦ÇѹÝÀÀ.
  • reaction accelerator
    ¹ÝÀÀÃËÁøÃ¼(Úãëë õµòäô÷).
  • reaction center
    Ȱ¼ºÁß½É(üÀàõñéãý).
  • reaction deficiency
    ¹ÝÀÀ°áÇÌ
  • reaction fever
    ¹ÝÀÀ¿­(Úãëëæð).
  • reaction formation
    ¹ÝÀÀÇü¼º(Úãëëû¡à÷).(Á¤½Å)¹Ýµ¿Çü¼º(ÚãÔÑû¡à÷).
  • reaction isochore
    ¹ÝÀÀÇ׿ë½Ä(ÚãëëùöéÄãÒ).
  • reaction kinetics
    ¹ÝÀÀ¼Óµµ·Ð(ÚãëëáÜöôÖå).
  • reaction of identity
    ÀÏÄ¡¹ÝÀÀ
  • reaction of non-identity
    ºÒÀÏÄ¡¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • elevator reaction
    ½Â°­±â¹ÝÀÀ(ã°Ë½Ñ¦Úãëë).
  • emergency reaction
    ±ä±Þ¹ÝÀÀ.
  • endoergic reaction
    ³»Àμº¹ÝÀÀ
  • endothermic reaction
    Èí¿­¹ÝÀÀ(ýåæðÚãëë).
  • enzyme-antienzyme reaction
    È¿¼ÒÇ×È¿¼Ò¹ÝÀÀ.
  • eosinophilic leukemoid reaction
    È£»ê±¸¼º ¹éÇ÷º´¾ç¹ÝÀÀ
  • erythremoid reaction
    ÀûÇ÷º´¾ç¹ÝÀÀ.
  • erythrocyte sedimentation reaction
    ÀûÇ÷±¸Ä§°­¹ÝÀÀ.
  • escape reaction
    µµÇǹÝÀÀ(Ô±ù­Úãëë).
  • exergonic reaction
    ¹ß¿­¹ÝÀÀ<¿¡³ÊÁö¹ß»ý¹ÝÀÀ>, ¿¡³ÊÁö¹æÃâ¹ÝÀÀ.
  • exoergic reaction
    ¿ÜÀμº¹ÝÀÀ
  • exothermic reaction
    ¹ß¿­¹ÝÀÀ(Û¡æðÚãëë).
  • explosive reaction
    Æø¹ß¹ÝÀÀ.
  • false negative reaction
    °¡À½¼º ¹ÝÀÀ.
  • false positive reaction
    °¡¾ç¼º ¹ÝÀÀ.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • time constant of a reaction
    ¹ÝÀÀ ½Ã°£»ó¼ö (ÚãëëãÁÊàßÈâ¦)
  • trigger reaction
    ¹æ¾Æ¼è ¹ÝÀÀ(Úãëë)
  • unimolecular reaction
    ÀϺÐÀÚ(ìéÝÂí­) ¹ÝÀÀ (Úãëë)
  • uphill reaction
    ¿À¸£¸· ¹ÝÀÀ (Úãëë)
  • van den Bergh reaction
    ¹Ý µ§ º£¸£±× ¹ÝÀÀ (Úãëë)
  • vectorial reaction
    ÁöÇâ(ò¦ú¾) ¹ÝÀÀ (Úãëë)
  • xanthoproteic reaction
    Ȳ´Ü¹éÁú(üÜÓ±ÛÜòõ) ¹ÝÀÀ(Úãëë)
  • yellow protein reaction
    Ȳ»ö ´Ü¹éÁú(üÜßäÓ±ÛÜòõ) ¹ÝÀÀ (Úãëë)
  • zero-order reaction
    ¿µÂ÷(çÍó­) ¹ÝÀÀ(Úãëë)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 10
ASSR adult situation stress reaction
BFPR biologic false-positive reaction
BFR biologic false reaction; blood flow rate; bone formation rate; buffered Ringer [solution]
BRT Brook reaction test
BW bacteriological warfare; bed wetting; below waist; biological warfare; biological weapon; birth weig...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 10
PCR Polymerase chain reaction assay
PCR-SSO Polymerase chain reaction sequence-specific oligonucleotide
PCR-SSCP Polymerase chain reaction single strand conformational polymorphism
PCR-SSP Polymerase chain reaction with sequence specific primers
PCR-DGGE Polymerase chain reaction-denaturing gradient gel electrophoresis
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
coombs' reaction An immunological lab test to detect antibodies which attack the red blood cells of its own body (called autoantibodies). The test is important to the diagnosis of certain blood disorders. The test first reacts red blood cells with serum from the test individual, then with antibodies to the autoantibodies. If the autoantibodies exist, they will bind to the red blood cells. When the antibodies to the autoantibodies are added, they will bind the autoantibodies (still attached to the red blood cells) and cause the red blood cells to clump together. Large clumps of red blood cells indicate that the autoantibodies exist, absence of the clumps indicates that they don't.
(09 Oct 1997)
myasthenic reaction Rapid loss of response to faradic stimulation of a muscle with the galvanic response and the power of voluntary contraction retained.
Synonym: myasthenic reaction.
(05 Mar 2000)
cortical reaction The reaction of an egg cell to fertilization which changes its surface cell membrane and prevents additional sperm cells from entering (among other things).
(09 Oct 1997)
polymerase chain reaction <molecular biology, technique> The first practical system for in vitro amplification of DNA and as such one of the most important recent developments in molecular biology.
Two synthetic oligonucleotide primers, which are complementary to two regions of the target DNA (one for each strand) to be amplified, are added to the target DNA (that need not be pure), in the presence of excess deoxynucleotides and Taq polymerase, a heat stable DNA polymerase. In a series (typically 30) of temperature cycles, the target DNA is repeatedly denatured (around 90_C), annealed to the primers (typically at 50-60_C) and a daughter strand extended from the primers (72_C). As the daughter strands themselves act as templates for subsequent cycles, DNA fragments matching both primers are amplified exponentially, rather than linearly.
The original DNA need thus be neither pure nor abundant and the polymerase chain reaction has accordingly become widely used not only in research, but in clinical diagnostics and forensic science.
Acronym: PCR
(14 Oct 1997)
myelocytic leukemoid reaction Leukocytosis of at least moderate degree, e.g., 50,000 or more per cu mm, with a few immature forms, e.g., 1 or 2% myelocytes, but chiefly mature polymorphonuclear leukocytes in the circulating blood; may be observed in association with tuberculosis, chronic osteomyelitis, various types of empyema, malaria, pneumococcal pneumonia, meningococcal meningitis, Hodgkin's disease, and metastases of carcinoma in the bone marrow.
(05 Mar 2000)
coupled reaction Two chemical reactions that share a common intermediate (for example, the productof the first reaction is a reactant in the second) and therefore havesome kind of energy exchange between them.
(09 Oct 1997)
Porter-Silber reaction The basis of the 17-hydroxycorticosteroid test; C-21 adrenocorticosteroids, which contain a dihydroxyacetone group at carbons 19, 20, and 21, react with phenylhydrazine.
(05 Mar 2000)
Haber-Weiss reaction The reaction of superoxide (O2-- with hydrogen peroxide to produce molecular oxygen (O2), hydroxide radical (OH-), and OH-; often, iron catalyzed; a source of oxidative stress in blood cells and various tissues.
(05 Mar 2000)
cross reaction <haematology, immunology> Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen.
(12 Dec 1998)
haemoclastic reaction Haemolysis as observed in the laking of the blood.
(05 Mar 2000)
cutaneous graft versus host reaction An acute erythematous maculopapular reaction with bulla formation in the most severe cases; chronic changes may resemble lichen planus or scleroderma.
(05 Mar 2000)
cutaneous reaction The inflammatory reaction in the case of a skin test in a sensitive (allergic) subject.
Synonym: cutaneous reaction.
Origin: L. Cutis, skin, + reaction
(05 Mar 2000)
Prausnitz-Kustner reaction A test for the presence of immediate hypersensitivity in humans; test serum from an atopic individual is injected intradermally into a normal subject; the normal subject is challenged 24-48 hours later with the antigen suspected of causing the immediate hypersensitivity reaction in the atopic individual.
Synonym: P-K test.
(05 Mar 2000)
precipitin reaction See: precipitin, precipitin test.
(05 Mar 2000)
harlequin reaction Sudden blanching of the lower half of the body of an infant lying on its side, leaving the remaining half of the body the normal pink colour.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 10
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 10
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 10
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 10
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 10
ÅëÇÕ°Ë»ö ¿Ï·á